Mercy Medical Center’s Institute for Foot and Ankle Reconstruction (IFAR), recognized as a leading destination for specialized foot and ankle care, has introduced the Center for Orthopedic Innovation. The advanced …
Cumulus Neuroscience (Cumulus), a global digital health company dedicated to improving neuroscience research and patient care through advanced digital data collection, has unveiled new findings on its Symbol Swap digital …
Creyos, a global provider of digital cognitive and behavioral health assessment solutions, has announced that its technology is featured in two research posters at the Alzheimer’s Association International Conference (AAIC) …
AISAP, an FDA-cleared artificial intelligence platform designed for point-of-care ultrasound (POCUS), has been highlighted as Case Study #5 in the World Health Organization’s latest report, Bridging Theory and Practice (page …
SetPoint Medical, a commercial-stage medical technology company focused on advancing treatment options for individuals with chronic autoimmune disorders, has announced the successful completion of the first implantation of the SetPoint …
At the 17th Annual Meeting of the New Champions (Summer Davos 2026), organized by the World Economic Forum in Dalian on June 23, Gong Yingying, Founder and Chairwoman of Yidu …
NS Pharma, Inc., headquartered in Paramus, New Jersey, has announced that its parent organization, Nippon Shinyaku Co., Ltd. of Kyoto, Japan, has signed a Sponsored Research Agreement (SRA) with Boston …
Intensity Therapeutics, Inc., a late-stage biotechnology firm, focuses on discovering and developing proprietary cancer treatments using its non-covalent drug-conjugation technology. This approach is designed to destroy tumors while enhancing the …
Jazz Pharmaceuticals plc announced that it will share six research abstracts—including one oral presentation—at the 2026 American Academy of Neurology (AAN) Annual Meeting, scheduled for April 18–22, 2026, in Chicago. …
Harbour BioMed, a global biopharmaceutical company focused on advancing innovative antibody-based therapies in immunology and immune-oncology, has announced the online publication of results from the first-in-human Phase I clinical trial …
Hyundai Bioscience has revealed an ambitious new plan aimed at addressing worldwide viral outbreaks, confirming the launch of its Phase 2 clinical trials in the United States. During its presentation …
Clover Biopharmaceuticals, Ltd, a global biotechnology company with commercial-stage operations and a focus on developing innovative vaccines to protect lives and enhance public health worldwide, has announced the completion of …
At Kenvue, we explore, collaborate, experiment, and refine – transforming innovative ideas into tangible, real-world solutions. By harnessing advanced science and technology, we work tirelessly to earn the confidence of …
For the more than half a million Americans receiving dialysis, treatment doesn’t end when they leave the center. Many patients manage complex medication regimens at home, often taking more than …
The Robert A. Winn Clinical Investigator Pathway Program (Winn CIPP) Launches Fourth Cohort The Robert A. Winn Clinical Investigator Pathway Program (Winn CIPP), a national initiative led by VCU Massey …
Clinical trials play a vital role in the development of healthcare products, and there is an increasing awareness of the need for more diversity in participant pools. With the recent …
Dr. Eva Natukunda, a pediatric HIV specialist at the Joint Clinical Research Center in Kampala, Uganda, often hears from adolescents and young adults living with HIV that they are exhausted. …
